Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer

Oncology Letters

Volumn 8, Issue 2, 2014, Pages 789-794

  Ma, Chao ^a   Liu, Chunxiao ^a   Huang, Peng ^a,b,c   Kaku, Haruki ^b,c   Chen, Jie ^b,c   Guo, Kai ^a,b,c   Ueki, Hideo ^c   Sakai, Akiko ^c   Nasu, Yasutomo ^b,c   Kumon, Hiromi ^c   Shimizu, Kenji ^c   Watanabe, Masami ^b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Axin2; Prostate cancer; Rs2240308; Single nucleotide polymorphism; Wnt signaling pathway

Indexed keywords

AXIS INHIBITION PROTEIN 2; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; GENE; GENETIC ANALYSIS; GENOTYPE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; WNT SIGNALING PATHWAY;

EID: 84902331662     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2177     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Wolk A: Diet, lifestyle and risk of prostate cancer. Acta Oncol 44: 277-281, 2005.
3. Eeles RA, Kote-Jarai Z, Giles GG, et al: Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321, 2008.
4. Gudmundsson J, Sulem P, Manolescu A, et al: Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39: 631-637, 2007.
5. Pishvaian MJ and Byers SW: Biomarkers of WNT signaling. Cancer Biomark 3: 263-274, 2007.
6. Neth P, Ries C, Karow M, Egea V, Ilmer M and Jochum M: The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. Stem Cell Rev 3: 18-29, 2007.
7. Akiyama T: Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 11: 273-282, 2000.
8. Kikuchi A: Modulation of Wnt signaling by Axin and Axil. Cytokine Growth Factor Rev 10: 255-265, 1999.
9. Behrens J, Jerchow BA, Würtele M, et al: Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599, 1998.
10. Liu W, Dong X, Mai M, et al: Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26: 146-147, 2000.
11. Mai M, Qian C, Yokomizo A, Smith DI and Liu W: Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24. Genomics 55: 341-344, 1999.
12. Dong X, Seelan RS, Qian C, Mai M and Liu W: Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene. Cytogenet Cell Genet 93: 26-28, 2001.
13. Pinarbasi E, Gunes EG, Pinarbasi H, Donmez G and Silig Y: AXIN2 polymorphism and its association with prostate cancer in a Turkish population. Med Oncol 28: 1373-1378, 2011.
14. Kanzaki H, Ouchida M, Hanafusa H, et al: Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. Int J Mol Med 18: 279-284, 2006.
15. Gunes EG, Pinarbasi E, Pinarbasi H and Silig Y: Strong association between lung cancer and the AXIN2 polymorphism. Mol Med Rep 2: 1029-1035, 2009.
16. Greene FL (ed): AJCC Cancer Staging Manual. Vol 1. 6th edition. Springer, New York, NY, 2002.
17. Montironi R, Cheng L, Lopez-Beltran A, et al: Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports. Eur Urol 58: 369-773, 2010.
18. Epstein JI, Allsbrook WC Jr., Amin MB and Egevad LL; ISUP Grading Committee: The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228-1242, 2005.
19. Wang L, Kaku H, Huang P, et al: Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects. Acta Med Okayama 65: 315-323, 2011.
20. Khan NP, Pandith AA, Hussain MU, Yousuf A, Khan MS, Wani KA and Mudassar S: Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: a study in Kashmiri population. Mol Cell Biochem 355: 149-155, 2011.
21. Webster MT, Rozycka M, Sara E, et al: Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer 28: 443-453, 2000.
22. Koch A, Hrychyk A, Hartmann W, et al: Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. Int J Cancer 121: 284-291, 2007.